First-line therapy for HGBL, NOS. Recommendations are based on available experience in aggressive lymphomas and the authors’ preferences, because histology-specific data are sparse; areas of priority research are italicized. HDMTX, high-dose methotrexate; iPET, interim positron emission tomography; IT, intrathecal; PR, partial response; RT, radiation therapy.